Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amal Robay

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Cardiovascular Diabetology|June 7, 2024
Dysregulation of long non-coding RNA gene expression pathways in monocytes of type 2 diabetes patients with cardiovascular diseaseNajeeb Halabi, Binitha Thomas, Omar Chidiac, et al.
The Journal of Biological Chemistry|April 29, 2011
ERp29 regulates DeltaF508 and wild-type cystic fibrosis transmembrane conductance regulator (CFTR) trafficking to the plasma membrane in cystic fibrosis (CF) and non-CF epithelial cellsLaurence Suaud, Katelyn Miller, Lora Alvey, et al.
Cold Spring Harbor Molecular Case Studies|November 24, 2021
Novel <i>MYO5B</i> mutation in microvillous inclusion disease of Syrian ancestryKamal Hassan, Amal Robay, Aljazi Al-Maraghi, et al.
Diabetes|November 4, 2021
Metabolic and Metabo-Clinical Signatures of Type 2 Diabetes, Obesity, Retinopathy, and DyslipidemiaNoha A Yousri, Karsten Suhre, Esraa Yassin, et al.
Cardiovascular Diabetology|February 3, 2022
Angiogenic content of microparticles in patients with diabetes and coronary artery disease predicts networks of endothelial dysfunctionIsra Marei, Omar Chidiac, Binitha Thomas, et al.
Therapeutic Advances in Chronic Disease|October 16, 2020
Association of vitamin D<sub>3</sub> and its metabolites in patients with and without type 2 diabetes and their relationship to diabetes complicationsAlexandra E Butler, Soha R Dargham, Aishah Latif, et al.
Molecular Therapy. Methods & Clinical Development|December 13, 2023
Predicted deleterious variants in the human genome relevant to gene therapy with adeno-associated virus vectorsMahboubeh R Rostami, Philip L Leopold, Jenifer M Vasquez, et al.
BMC Endocrine Disorders|May 17, 2020
Association of vitamin D<sub>2</sub> and D<sub>3</sub> with type 2 diabetes complicationsLina H M Ahmed, Alexandra E Butler, Soha R Dargham, et al.
The Pharmacogenomics Journal|May 21, 2026
Impact of population-specific pharmacogenomic variants on drug dosing in ICU patientsMahboubeh R Rostami, Juan Rodriguez-Flores, Ali Ait Hssain, et al.
BMC Medical Genetics|November 19, 2016
Two hits in one: whole genome sequencing unveils LIG4 syndrome and urofacial syndrome in a case report of a child with complex phenotypeAbeer Fadda, Fiza Butt, Sara Tomei, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Cardiovascular Diabetology|June 7, 2024
Dysregulation of long non-coding RNA gene expression pathways in monocytes of type 2 diabetes patients with cardiovascular diseaseNajeeb Halabi, Binitha Thomas, Omar Chidiac, et al.
The Journal of Biological Chemistry|April 29, 2011
ERp29 regulates DeltaF508 and wild-type cystic fibrosis transmembrane conductance regulator (CFTR) trafficking to the plasma membrane in cystic fibrosis (CF) and non-CF epithelial cellsLaurence Suaud, Katelyn Miller, Lora Alvey, et al.
Cold Spring Harbor Molecular Case Studies|November 24, 2021
Novel <i>MYO5B</i> mutation in microvillous inclusion disease of Syrian ancestryKamal Hassan, Amal Robay, Aljazi Al-Maraghi, et al.
Diabetes|November 4, 2021
Metabolic and Metabo-Clinical Signatures of Type 2 Diabetes, Obesity, Retinopathy, and DyslipidemiaNoha A Yousri, Karsten Suhre, Esraa Yassin, et al.
Cardiovascular Diabetology|February 3, 2022
Angiogenic content of microparticles in patients with diabetes and coronary artery disease predicts networks of endothelial dysfunctionIsra Marei, Omar Chidiac, Binitha Thomas, et al.
Therapeutic Advances in Chronic Disease|October 16, 2020
Association of vitamin D<sub>3</sub> and its metabolites in patients with and without type 2 diabetes and their relationship to diabetes complicationsAlexandra E Butler, Soha R Dargham, Aishah Latif, et al.
Molecular Therapy. Methods & Clinical Development|December 13, 2023
Predicted deleterious variants in the human genome relevant to gene therapy with adeno-associated virus vectorsMahboubeh R Rostami, Philip L Leopold, Jenifer M Vasquez, et al.
BMC Endocrine Disorders|May 17, 2020
Association of vitamin D<sub>2</sub> and D<sub>3</sub> with type 2 diabetes complicationsLina H M Ahmed, Alexandra E Butler, Soha R Dargham, et al.
The Pharmacogenomics Journal|May 21, 2026
Impact of population-specific pharmacogenomic variants on drug dosing in ICU patientsMahboubeh R Rostami, Juan Rodriguez-Flores, Ali Ait Hssain, et al.
BMC Medical Genetics|November 19, 2016
Two hits in one: whole genome sequencing unveils LIG4 syndrome and urofacial syndrome in a case report of a child with complex phenotypeAbeer Fadda, Fiza Butt, Sara Tomei, et al.
Pageof 4